Utah Medical Products, Inc. (NASDAQ:UTMD) Short Interest Update

Utah Medical Products, Inc. (NASDAQ:UTMD) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 63,800 shares, a growth of 27.1% from the August 31st total of 50,200 shares. Based on an average trading volume of 19,200 shares, the short-interest ratio is presently 3.3 days. Approximately 2.0% of the shares of the company are short sold.

Institutional Trading of Utah Medical Products

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rhumbline Advisers grew its stake in shares of Utah Medical Products by 17.3% in the second quarter. Rhumbline Advisers now owns 5,508 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 812 shares during the last quarter. Cardinal Capital Management grew its position in Utah Medical Products by 6.2% during the second quarter. Cardinal Capital Management now owns 15,645 shares of the medical instruments supplier’s stock worth $1,050,000 after buying an additional 908 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Utah Medical Products by 4.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock valued at $1,632,000 after acquiring an additional 947 shares during the period. Allspring Global Investments Holdings LLC acquired a new position in Utah Medical Products in the 2nd quarter valued at approximately $83,000. Finally, Bridge City Capital LLC grew its holdings in shares of Utah Medical Products by 43.4% during the 1st quarter. Bridge City Capital LLC now owns 4,555 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 1,379 shares in the last quarter. Institutional investors and hedge funds own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

UTMD opened at $66.74 on Monday. Utah Medical Products has a twelve month low of $65.60 and a twelve month high of $89.15. The business has a 50 day moving average price of $67.77 and a 200 day moving average price of $68.09. The firm has a market cap of $235.46 million, a P/E ratio of 14.83 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter. The business had revenue of $10.40 million during the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%.

Utah Medical Products Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 4th. Investors of record on Friday, September 20th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. Utah Medical Products’s dividend payout ratio is presently 26.67%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.